The authors have informed the Publisher about an update in the above-mentioned article. The DOI of the original article is: https://doi.org/10.1055/s-0041-1740323 (published efirst on February 2, 2022). The changes are presented in bold in the following two sentences:

1. The sentence “The progression-free survival observed in these patients was 28 months and 36.3 months, respectively.” in the abstract should be read as “The progression-free survival observed in these patients was 28 months and 45 months, respectively.”

2. The sentence on page 2 left hand side column 8th paragraph “Patient 2 (BSK) has had a PFS of 36.3 months and has shown no signs of relapse at the time of submitting the manuscript.” should be read as “Patient 2 (BSK) has had a PFS of 45 months and has shown no signs of relapse at the time of submitting the manuscript.”

   
   

Conflict of Interest

None declared.

Address for correspondence

Publication History

Article published online:
21 April 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India